New Haven pharmaceutical company moving headquarters to Boston
NEW HAVEN, Conn. (AP) — Alexion Pharmaceuticals Inc. has announced that it is relocating its headquarters from New Haven, Connecticut to Boston.
In what it calls a plan to "re-align the global organization with its refocused corporate strategy," the company also announced Tuesday it is cutting 20 percent of its workforce.
The company said about 400 jobs will move to Boston by the middle of next year. The company will maintain a research and development center in New Haven with about 450 employees.
Alexion said the moves are expected to save about $270 million annually, and allow the reinvestment of about $100 million a year into research and development.
Chief Executive Officer Ludwig Hantson says the moves "will create a leaner organization with greater financial flexibility."
Alexion developed Soliris, a high-priced treatment for two rare genetic disorders.
Stories that may interest you
Some flights to and from the U.S. have been canceled even after AT&T and Verizon scaled back the rollout of high-speed wireless service that could interfere with aircraft technology that measures altitude
For Foxwoods and Mohegan Sun, the omicron surge took latest toll on pandemic-battered business.
Internet Protocol TV, using home WiFi, can deliver video channels, on-demand programs and streaming providers.
The program, through the Women's Business Development Council, has given out $924,000 in 98 grants since December 2020.